poloxalene has been researched along with Acute Promyelocytic Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boucher, KM; Kaur, I; Kern, SE; Kosak, KM; Shami, PJ; Terrazas, M | 1 |
1 other study(ies) available for poloxalene and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles.
Topics: Antineoplastic Agents; Azo Compounds; Cell Nucleus; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Micelles; Nitric Oxide; Nitric Oxide Donors; Nuclear Proteins; Piperazines; Poloxalene; Prodrugs; Protein Processing, Post-Translational; Solubility | 2013 |